DMTKQ Stock - DermTech, Inc.
Unlock GoAI Insights for DMTKQ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $15.30M | $14.52M | $11.84M | $5.88M | $3.36M |
| Gross Profit | $276,000 | $647,000 | $1.27M | $-96,000 | $60,000 |
| Gross Margin | 1.8% | 4.5% | 10.8% | -1.6% | 1.8% |
| Operating Income | $-103,739,000 | $-118,165,000 | $-77,398,000 | $-35,289,000 | $-17,605,000 |
| Net Income | $-100,888,000 | $-116,683,000 | $-78,335,000 | $-36,477,000 | $-20,130,000 |
| Net Margin | -659.6% | -803.7% | -661.7% | -619.8% | -598.4% |
| EPS | $-3.09 | $-3.88 | $-2.71 | $-2.15 | $-2.81 |
DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the psoriasis, atopic dermatitis, and aging of the skin to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California. On June 18, 2024, DermTech, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Visit WebsiteEarnings History & Surprises
DMTKQEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 5, 2025 | — | — | — | — |
Q2 2025 | May 22, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | $-0.52 | — | — | — |
Q3 2024 | Aug 29, 2024 | $-0.52 | $-0.52 | 0.0% | = MET |
Q2 2024 | May 14, 2024 | $-0.62 | $-0.58 | +6.5% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | $-0.57 | $-0.56 | +1.6% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $-0.76 | $-0.57 | +25.9% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $-0.97 | $-0.99 | -1.4% | ✗ MISS |
Q2 2023 | May 4, 2023 | $-0.91 | $-1.02 | -12.0% | ✗ MISS |
Q1 2023 | Mar 2, 2023 | $-0.96 | $-0.93 | +3.1% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $-0.99 | $-0.96 | +3.4% | ✓ BEAT |
Q3 2022 | Aug 8, 2022 | $-1.01 | $-0.99 | +2.6% | ✓ BEAT |
Q2 2022 | May 3, 2022 | — | $-1.01 | — | — |
Q1 2022 | Mar 10, 2022 | — | $-0.88 | — | — |
Q4 2021 | Nov 9, 2021 | — | $-0.68 | — | — |
Q3 2021 | Aug 4, 2021 | — | $-0.59 | — | — |
Q2 2021 | May 13, 2021 | — | $-0.55 | — | — |
Q1 2021 | Mar 5, 2021 | — | $-0.43 | — | — |
Q4 2020 | Nov 10, 2020 | — | $-0.49 | — | — |
Latest News
Frequently Asked Questions about DMTKQ
What is DMTKQ's current stock price?
What is the analyst price target for DMTKQ?
What sector is DermTech, Inc. in?
What is DMTKQ's market cap?
Does DMTKQ pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to DMTKQ for comparison